Verrica Pharmaceuticals - Biopharmaceutical Firm Hopes To Raise $75 Million In IPO

Verrica Pharmaceuticals – a biopharmaceutical firm that focuses on identifying, developing and commercializing innovative solutions to unmet needs in medical dermatology – is going public on Wednesday, June 14, 2018.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.